Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bartek

Showing results (41-50 of 223) with videos related to

Pageof 23
Sort By:
Vnitrni Lekarstvi|July 28, 1999
[Leptinemia in persons with acute myocardial infarct]D Stejskal, V Růzicka, J Bartek, et al.
The Journal of Biological Chemistry|August 2, 1996
Abrogation of p27Kip1 by cDNA antisense suppresses quiescence (G0 state) in fibroblastsN Rivard, G L'Allemain, J Bartek, et al.
Vnitrni Lekarstvi|November 20, 1998
[Leptin, insulin and proinsulin--their relationship]D Stejskal, L Jedelský, J Bartek, et al.
The Journal of Pathology|March 1, 1994
Cell cycle-related variation and tissue-restricted expression of human cyclin D1 proteinJ Bartkova, J Lukas, M Strauss, et al.
Oncogene|September 25, 1998
Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiationJ Bartkova, J Lukas, M Strauss, et al.
Rozhledy V Chirurgii : Mesicnik Ceskoslovenske Chirurgicke Spolecnosti|June 1, 1997
[Significance of monitoring cytokine levels in the prognosis of acute pancreatitis]V Král, R Havlík, T Grosmanová, et al.
Cancer Research|November 1, 1995
Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 controlJ Lukas, L Aagaard, M Strauss, et al.
Oncogene|July 18, 1996
Enhanced protein stability: a novel mechanism of D-type cyclin over-abundance identified in human sarcoma cellsM Welcker, J Lukas, M Strauss, et al.
International Journal of Cancer|August 15, 1994
The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomasJ Bartkova, J Lukas, M Strauss, et al.
Vnitrni Lekarstvi|March 1, 1989
[Initial experience with thin-needle biopsy under ultrasonic control in diffuse liver diseases]M Sorf, V Krislo, I Jablonský, et al.
Pageof 23

Showing results (41-50 of 223) with videos related to

Sort By:
Pageof 23
Vnitrni Lekarstvi|July 28, 1999
[Leptinemia in persons with acute myocardial infarct]D Stejskal, V Růzicka, J Bartek, et al.
The Journal of Biological Chemistry|August 2, 1996
Abrogation of p27Kip1 by cDNA antisense suppresses quiescence (G0 state) in fibroblastsN Rivard, G L'Allemain, J Bartek, et al.
Vnitrni Lekarstvi|November 20, 1998
[Leptin, insulin and proinsulin--their relationship]D Stejskal, L Jedelský, J Bartek, et al.
The Journal of Pathology|March 1, 1994
Cell cycle-related variation and tissue-restricted expression of human cyclin D1 proteinJ Bartkova, J Lukas, M Strauss, et al.
Oncogene|September 25, 1998
Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiationJ Bartkova, J Lukas, M Strauss, et al.
Rozhledy V Chirurgii : Mesicnik Ceskoslovenske Chirurgicke Spolecnosti|June 1, 1997
[Significance of monitoring cytokine levels in the prognosis of acute pancreatitis]V Král, R Havlík, T Grosmanová, et al.
Cancer Research|November 1, 1995
Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 controlJ Lukas, L Aagaard, M Strauss, et al.
Oncogene|July 18, 1996
Enhanced protein stability: a novel mechanism of D-type cyclin over-abundance identified in human sarcoma cellsM Welcker, J Lukas, M Strauss, et al.
International Journal of Cancer|August 15, 1994
The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomasJ Bartkova, J Lukas, M Strauss, et al.
Vnitrni Lekarstvi|March 1, 1989
[Initial experience with thin-needle biopsy under ultrasonic control in diffuse liver diseases]M Sorf, V Krislo, I Jablonský, et al.
Pageof 23